Skip to main content
S 1113 115th Congress Senate Health Animal protection and human-animal relationships Business records Coal Consumer affairs Department of Health and Human Services Drug safety, medical device, and laboratory regulation Employee hiring Federal preemption Food and Drug Administration (FDA) Government information and archives Inflation and prices Licensing and registrations Manufacturing Product safety and quality Small business State and local government operations User charges and fees

Personal Care Products Safety Act

Introduced: May 11, 2017 See on congress.gov
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 11, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2918-2919)
May 11, 2017
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Personal Care Products Safety Act

This bill amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. Companies must pay a facility registration fee based on their annual gross sales of cosmetics. The collected fees can only be used for cosmetic safety activities.

If the FDA determines that a cosmetic has a reasonable probability of causing serious adverse health consequences, it may prohibit the cosmetic's distribution by suspending the cosmetic ingredient statement. If other cosmetics from the same facility may be affected, the FDA may prohibit distribution from the facility by suspending the facility's registration.

The FDA must review the safety of at least five cosmetic ingredients each year, and it may establish conditions for safe use of an ingredient, including a limit on the amount of the ingredient or a requirement for a warning label. A cosmetic cannot be sold if it contains an ingredient that is not safe, not safe under the recommended conditions of use, or not safe in the amount present in the cosmetic.

Cosmetics companies are required to report to the FDA any serious adverse health event associated with their cosmetics.

The FDA must:

  • develop and implement cosmetic manufacturing standards that are consistent with existing national and international standards,
  • be allowed to inspect a company's cosmetic safety records,
  • recall a cosmetic that is likely to cause serious adverse health consequences, and
  • encourage cosmetic safety testing practices that minimize the use of animals.
What's happening now May 11, 2017

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2918-2919)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1113: Personal Care Products Safety Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-1113/
MLA
"S. 1113: Personal Care Products Safety Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-1113/.
Bluebook (legal)
S. 1113, 115th Cong. (2026), https://openamerica.io/bill/115-S-1113/.
Markdown link
[S. 1113: Personal Care Products Safety Act](https://openamerica.io/bill/115-S-1113/)
Report a problem